세계의 담즙정체성 가려움증 시장 보고서(2025년)

Cholestatic Pruritus Global Market Report 2025

US $ 4,490 ￦ 6,342,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,490 ￦ 9,167,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,490 ￦ 11,992,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

담즙정체성 가려움증 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 2029년은 연간 평균 성장률(CAGR) 5.3%로 성장할 전망이며, 249억 7,000만 달러로 성장이 예측됩니다. 예측 기간 성장은 노인인구 증가, 아토피피부염 및 두드러기 유병률 증가, 만성신장병 이환율 증가, 소양증과 관련된 질환의 유병률 증가에 기인할 것으로 전망됩니다. 이 기간 주요 동향으로는 새로운 치료 옵션 도입, 담즙정체성 가려움증 연구를 위한 대기업과의 제휴, 치료 방법의 혁신, 헬스케어 시설 확대, 치료 기술 진보 등을 들 수 있습니다.

간 질환의 유병률 증가는 담즙정체성 가려움증 시장의 성장을 가속할 것으로 예측됩니다. 간질환에는 감염병, 자가면역질환, 유전적 질환, 독소에 의한 손상 등 간 기능을 손상시키는 폭넓은 질환이 포함되며, 이 모든 것이 염증이나 흉터화, 심지어 간부전으로 이어질 수 있습니다. 비만율 상승, 당뇨병, 음주, 바이러스성 간염, 환경독소 노출 등의 요인이 간질환 유병률 상승에 기여하고 있습니다. 담즙정체성 가려움증은 담즙의 흐름이 나빠지고 있음을 나타내며, 종종 간 기저질환의 추가적인 조사 및 치료를 촉진하기 때문에 간 질환을 특정하고 관리하기 위한 중요한 증상입니다. 예를 들어 2023년 7월, 건강격차 시정에 중점을 둔 영국 정부기관인 Office for Health Improvement and Disparities는 잉글랜드에서 간질환으로 인한 입원환자 수가 2022년까지 1년간 67,458명에서 82,290명으로 22% 증가했다고 보고했습니다. 이처럼 간질환의 이환율 증가는 담즙정체성 가려움증 시장에서의 치료 수요의 원동력이 될 것으로 보입니다.

담즙정체성 가려움증 시장의 주요 기업은 증상을 보다 잘 관리하고, 환자의 컴플라이언스를 향상시키며, 담즙산염의 축적과 염증의 근본 원인에 대처함으로써 적당한 완화를 제공하기 위해, 경구 솔루션 등의 혁신적인 치료법의 개발에 주력하고 있습니다. 담즙정체성 가려움증의 경구제는 담즙산의 축적을 억제해, 담즙울체 환자의 심한 가려움을 완화하도록 설계된 액체약입니다. 예를 들면, 2024년 3월, 미국을 거점으로 하는 바이오 의약품 회사인 Mirum Pharmaceuticals Inc.는, 5세 이상의 진행성 가족성 간내 담즙 정체(PFIC) 환자의 담즙정체성 가려움증 치료에 사용되는 LIVMARLI(maralixibat) 경구액의 승인을 미국 식품의약국(FDA)으로부터 취득했습니다. 본 약제는 1일 1회 경구투여 회장형 담즙산트랜스포터 저해제이며 PFIC 2형 획기적 치료제로 지정되어 있습니다. LIVMARLI는 PFIC와 관련된 담즙정체성 가려움증을 가진 환자, 특히 가장 희귀한 하위 유형을 가진 환자에게 갈망하던 치료 선택지를 제공합니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향 및 전략

제4장 시장-거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나 바이러스 감염의 영향과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석 및 전략 분석 프레임워크

• 세계의 담즙정체성 가려움증 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인 및 억제요인)
• 최종 이용 산업의 분석
• 세계의 담즙정체성 가려움증 시장 : 성장률 분석
• 세계의 담즙정체성 가려움증 시장 실적 : 규모 및 성장(2019-2024년)
• 세계의 담즙정체성 가려움증 시장 예측 : 규모 및 성장(2024-2029년, 2034년)
• 세계의 담즙정체성 가려움증 전체 시장 규모(TAM)

제6장 시장 세분화

• 세계의 담즙정체성 가려움증 시장 : 질환 유형별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
• 원발성 담즙성 담관염(PBC)
• 원발성 경화성 담관염(PSC)
• 임신성 간내 담즙울체(ICP)
• 기타 질병의 유형
• 세계의 담즙정체성 가려움증 시장 : 치료 유형별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
• 의약품
• 광선요법
• 기타 치료 유형
• 세계의 담즙정체성 가려움증 시장 : 투여 경로별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
• 오랄
• 주제
• 주사제
• 세계의 담즙정체성 가려움증 시장 : 최종 사용자별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
• 병원
• 클리닉
• 외래 진료 센터
• 홈케어
• 세계의 담즙정체성 가려움증 시장 : 원발성 담즙성 담관염(PBC) 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
• 초기 단계의 PBC
• 고급 PBC
• 간경변을 동반하는 PBC
• 간부전을 동반하는 PBC
• 세계의 담즙정체성 가려움증 시장 : 원발성 경화성 담관염(PSC) 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
• 클래식 PSC
• 궤양성 대장염을 동반한 PSC
• 담관 협착을 수반하는 PSC
• 세계의 담즙정체성 가려움증 시장 : 임신성 간내 담즙 정체(ICP) 병형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
• 경도의 두개내 압항진
• 심한 두개 내 압 항진증
• 조산 리스크를 수반하는 ICP
• 세계의 담즙정체성 가려움증 시장 : 기타 질환 유형별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
• 알코올성 담즙 정체
• 약제성 담즙 정체
• 바이러스성 간염 유발성 담즙 정체
• 유전성 담즙 울체질환

제7장 지역별 및 국가별 분석

• 세계의 담즙정체성 가려움증 시장 : 지역별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
• 세계의 담즙정체성 가려움증 시장 : 국가별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도 및 기업 프로파일

• 담즙정체성 가려움증 시장 : 경쟁 구도
• 담즙정체성 가려움증 시장 : 기업 프로파일
  • GlaxoSmithKline plc 개요, 제품 및 서비스, 전략 및 재무 분석
  • Takeda Pharmaceutical Company Limited 개요, 제품 및 서비스, 전략 및 재무 분석
  • Merck KGaA 개요, 제품 및 서비스, 전략 및 재무 분석
  • Regeneron Pharmaceuticals Inc. 개요, 제품 및 서비스, 전략 및 재무 분석
  • Bausch Health Companies Inc. 개요, 제품 및 서비스, 전략 및 재무 분석

제31장 기타 주요 기업 및 혁신 기업

• Incyte Corporation
• Ipsen Pharma
• Vanda Pharmaceuticals Inc.
• Medison Pharma Ltd.
• Mirum Pharmaceuticals Inc.
• Albireo Pharma Inc.
• Dipharma Francis Srl
• Cara Therapeutics Inc.
• CANbridge Pharmaceuticals Inc.
• Escient Pharmaceuticals Inc.
• Tharimmune Inc.
• Vifor Fresenius Medical Care Renal Pharma
• CymaBay Therapeutics Inc.
• ICE Pharma Inc.
• Aquatic Remedies Private Limited

제32장 세계 시장 경쟁 벤치마킹 및 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문 및 전략

• 담즙정체성 가려움증 시장(2029년) : 새로운 기회를 제공하는 국가
• 담즙정체성 가려움증 시장(2029년) : 새로운 기회를 제공하는 부문
• 담즙정체성 가려움증 시장(2029년) : 성장 전략
  • 시장 동향에 기초한 전략
  • 경쟁 전략

제36장 부록

AJY

영문 목차

영문목차

Cholestatic pruritus is a condition characterized by severe itching due to the accumulation of bile acids in the skin, often caused by liver diseases that hinder bile flow. This condition can greatly impact a patient's quality of life and typically requires targeted treatments to alleviate discomfort and address the underlying liver dysfunction.

The primary disease types associated with cholestatic pruritus include primary biliary cholangitis (PBC), primary sclerosing cholangitis (PSC), intrahepatic cholestasis of pregnancy (ICP), and other related conditions. Primary biliary cholangitis (PBC) is a chronic autoimmune liver disease that progressively destroys the bile ducts, causing bile accumulation, liver damage, and possibly cirrhosis. Treatment options for cholestatic pruritus include medications, phototherapy, and other treatments, with administration routes such as oral, topical, and injectable forms. The key end-users for these treatments include hospitals, clinics, ambulatory care centers, and home care settings.

The cholestatic pruritus market research report is one of a series of new reports from The Business Research Company that provides cholestatic pruritus market statistics, including the cholestatic pruritus industry global market size, regional shares, competitors with the cholestatic pruritus market share, detailed cholestatic pruritus market segments, market trends, and opportunities, and any further data you may need to thrive in the cholestatic pruritus industry. This cholestatic pruritus market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The cholestatic pruritus market size has grown strongly in recent years. It will grow from $19.20 billion in 2024 to $20.28 billion in 2025 at a compound annual growth rate (CAGR) of 5.6%. The growth during the historic period can be attributed to the increasing prevalence of skin disorders, higher investments in research and development, growing demand for effective treatments, greater awareness of the condition, and favorable regulatory environments.

The cholestatic pruritus market size is expected to see strong growth in the next few years. It will grow to $24.97 billion in 2029 at a compound annual growth rate (CAGR) of 5.3%. The growth in the forecast period can be attributed to the rising elderly population, the increasing prevalence of atopic dermatitis and urticaria, a higher incidence of chronic kidney diseases, and the growing prevalence of conditions associated with pruritus. Key trends during this period include the introduction of new treatment options, partnerships with major companies for cholestatic pruritus research, innovations in treatment modalities, the expansion of healthcare facilities, and technological advancements in care.

The increasing prevalence of liver diseases is expected to drive the growth of the cholestatic pruritus market. Liver diseases encompass a wide range of conditions that impair liver function, including infections, autoimmune disorders, genetic conditions, and damage from toxins, all of which can lead to inflammation, scarring, or even liver failure. Factors such as rising obesity rates, diabetes, alcohol consumption, viral hepatitis, and exposure to environmental toxins contribute to the growing prevalence of liver diseases. Cholestatic pruritus is an important symptom for identifying and managing liver diseases, as it signals impaired bile flow and often prompts further investigation and treatment of underlying liver conditions. For example, in July 2023, the Office for Health Improvement and Disparities, a UK government agency focused on reducing health inequalities, reported that hospital admissions for liver disease in England had risen by 22% in the year ending 2022, from 67,458 to 82,290. The increasing incidence of liver diseases will thus drive the demand for treatments in the cholestatic pruritus market.

Major companies in the cholestatic pruritus market are focusing on developing innovative treatments, such as oral solutions, to better manage symptoms, improve patient compliance, and provide targeted relief by addressing the root causes of bile salt buildup and inflammation. Oral solutions for cholestatic pruritus are liquid medications designed to reduce bile acid accumulation and alleviate severe itching in patients with cholestasis. For instance, in March 2024, Mirum Pharmaceuticals Inc., a U.S.-based biopharmaceutical company, received approval from the U.S. Food and Drug Administration (FDA) for LIVMARLI (maralixibat) oral solution, which is used to treat cholestatic pruritus in patients aged five and older with progressive familial intrahepatic cholestasis (PFIC). This once-daily, orally administered medication is an ileal bile acid transporter inhibitor and has been designated as a breakthrough therapy for PFIC type 2. LIVMARLI offers a much-needed treatment option for patients with cholestatic pruritus linked to PFIC, particularly for those with the rarest subtypes.

In September 2023, Travere Therapeutics Inc., a U.S.-based biopharmaceutical company, entered into a partnership with Mirum Pharmaceuticals Inc. Through this collaboration, Travere will focus on its core therapeutic areas while Mirum continues to expand its portfolio and develop and commercialize bile acid therapies for rare liver diseases. Mirum Pharmaceuticals is dedicated to advancing treatments for rare liver diseases, including those associated with cholestatic pruritus.

Major players in the cholestatic pruritus market are GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Merck KGaA, Regeneron Pharmaceuticals Inc., Bausch Health Companies Inc., Incyte Corporation, Ipsen Pharma, Vanda Pharmaceuticals Inc., Medison Pharma Ltd., Mirum Pharmaceuticals Inc., Albireo Pharma Inc., Dipharma Francis S.r.l., Cara Therapeutics Inc., CANbridge Pharmaceuticals Inc., Escient Pharmaceuticals Inc., Tharimmune Inc., Vifor Fresenius Medical Care Renal Pharma, CymaBay Therapeutics Inc., ICE Pharma Inc., and Aquatic Remedies Private Limited.

North America was the largest region in the cholestatic pruritus market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in cholestatic pruritus report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the cholestatic pruritus market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cholestatic pruritus market consists of revenues earned by entities by providing services such as diagnosis and screening services, medical consultations and treatment management, patient support programs, and counseling. The market value includes the value of related goods sold by the service provider or included within the service offering. The cholestatic pruritus market also includes sales of ursodeoxycholic acid, topical corticosteroids, and opioid antagonists. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cholestatic Pruritus Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cholestatic pruritus market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cholestatic pruritus ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cholestatic pruritus market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Disease Type: Primary Biliary Cholangitis (PBC); Primary Sclerosing Cholangitis (PSC); Intrahepatic Cholestasis of Pregnancy (ICP); Other Disease Types
• 2) By Treatment Type: Medications; Phototherapy; Other Treatment Types
• 3) By Route Of Administration: Oral; Topical; Injectable
• 4) By End-User: Hospitals; Clinics; Ambulatory Care Centers; Homecare
• Subsegments:
• 1) By Primary Biliary Cholangitis (PBC): Early-Stage PBC; Advanced PBC; PBC With Cirrhosis; PBC With Liver Failure
• 2) By Primary Sclerosing Cholangitis (PSC): Classic PSC; PSC With Ulcerative Colitis; PSC With Bile Duct Strictures
• 3) By Intrahepatic Cholestasis of Pregnancy (ICP): Mild ICP; Severe ICP; ICP With Preterm Birth Risk
• 4) By Other Disease Types: Alcoholic Cholestasis; Drug-Induced Cholestasis; Viral Hepatitis-Induced Cholestasis; Genetic Cholestasis Disorders
• Companies Mentioned: GlaxoSmithKline plc; Takeda Pharmaceutical Company Limited; Merck KGaA; Regeneron Pharmaceuticals Inc.; Bausch Health Companies Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Cholestatic Pruritus Market Characteristics

3. Cholestatic Pruritus Market Trends And Strategies

4. Cholestatic Pruritus Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Cholestatic Pruritus Growth Analysis And Strategic Analysis Framework

• 5.1. Global Cholestatic Pruritus PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Cholestatic Pruritus Market Growth Rate Analysis
• 5.4. Global Cholestatic Pruritus Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Cholestatic Pruritus Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Cholestatic Pruritus Total Addressable Market (TAM)

6. Cholestatic Pruritus Market Segmentation

• 6.1. Global Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Primary Biliary Cholangitis (PBC)
• Primary Sclerosing Cholangitis (PSC)
• Intrahepatic Cholestasis of Pregnancy (ICP)
• Other Disease Types
• 6.2. Global Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Medications
• Phototherapy
• Other Treatment Types
• 6.3. Global Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Topical
• Injectable
• 6.4. Global Cholestatic Pruritus Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Clinics
• Ambulatory Care Centers
• Homecare
• 6.5. Global Cholestatic Pruritus Market, Sub-Segmentation Of Primary Biliary Cholangitis (PBC), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Early-Stage PBC
• Advanced PBC
• PBC With Cirrhosis
• PBC With Liver Failure
• 6.6. Global Cholestatic Pruritus Market, Sub-Segmentation Of Primary Sclerosing Cholangitis (PSC), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Classic PSC
• PSC With Ulcerative Colitis
• PSC With Bile Duct Strictures
• 6.7. Global Cholestatic Pruritus Market, Sub-Segmentation Of Intrahepatic Cholestasis of Pregnancy (ICP), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Mild ICP
• Severe ICP
• ICP With Preterm Birth Risk
• 6.8. Global Cholestatic Pruritus Market, Sub-Segmentation Of Other Disease Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Alcoholic Cholestasis
• Drug-Induced Cholestasis
• Viral Hepatitis-Induced Cholestasis
• Genetic Cholestasis Disorders

7. Cholestatic Pruritus Market Regional And Country Analysis

• 7.1. Global Cholestatic Pruritus Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Cholestatic Pruritus Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Cholestatic Pruritus Market

• 8.1. Asia-Pacific Cholestatic Pruritus Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Cholestatic Pruritus Market

• 9.1. China Cholestatic Pruritus Market Overview
• 9.2. China Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Cholestatic Pruritus Market

• 10.1. India Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Cholestatic Pruritus Market

• 11.1. Japan Cholestatic Pruritus Market Overview
• 11.2. Japan Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Cholestatic Pruritus Market

• 12.1. Australia Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Cholestatic Pruritus Market

• 13.1. Indonesia Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Cholestatic Pruritus Market

• 14.1. South Korea Cholestatic Pruritus Market Overview
• 14.2. South Korea Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Cholestatic Pruritus Market

• 15.1. Western Europe Cholestatic Pruritus Market Overview
• 15.2. Western Europe Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Cholestatic Pruritus Market

• 16.1. UK Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Cholestatic Pruritus Market

• 17.1. Germany Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Cholestatic Pruritus Market

• 18.1. France Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Cholestatic Pruritus Market

• 19.1. Italy Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Cholestatic Pruritus Market

• 20.1. Spain Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Cholestatic Pruritus Market

• 21.1. Eastern Europe Cholestatic Pruritus Market Overview
• 21.2. Eastern Europe Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Cholestatic Pruritus Market

• 22.1. Russia Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Cholestatic Pruritus Market

• 23.1. North America Cholestatic Pruritus Market Overview
• 23.2. North America Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Cholestatic Pruritus Market

• 24.1. USA Cholestatic Pruritus Market Overview
• 24.2. USA Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Cholestatic Pruritus Market

• 25.1. Canada Cholestatic Pruritus Market Overview
• 25.2. Canada Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Cholestatic Pruritus Market

• 26.1. South America Cholestatic Pruritus Market Overview
• 26.2. South America Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Cholestatic Pruritus Market

• 27.1. Brazil Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Cholestatic Pruritus Market

• 28.1. Middle East Cholestatic Pruritus Market Overview
• 28.2. Middle East Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Cholestatic Pruritus Market

• 29.1. Africa Cholestatic Pruritus Market Overview
• 29.2. Africa Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Cholestatic Pruritus Market Competitive Landscape And Company Profiles

• 30.1. Cholestatic Pruritus Market Competitive Landscape
• 30.2. Cholestatic Pruritus Market Company Profiles
  • 30.2.1. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Regeneron Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Bausch Health Companies Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Cholestatic Pruritus Market Other Major And Innovative Companies

• 31.1. Incyte Corporation
• 31.2. Ipsen Pharma
• 31.3. Vanda Pharmaceuticals Inc.
• 31.4. Medison Pharma Ltd.
• 31.5. Mirum Pharmaceuticals Inc.
• 31.6. Albireo Pharma Inc.
• 31.7. Dipharma Francis S.r.l.
• 31.8. Cara Therapeutics Inc.
• 31.9. CANbridge Pharmaceuticals Inc.
• 31.10. Escient Pharmaceuticals Inc.
• 31.11. Tharimmune Inc.
• 31.12. Vifor Fresenius Medical Care Renal Pharma
• 31.13. CymaBay Therapeutics Inc.
• 31.14. ICE Pharma Inc.
• 31.15. Aquatic Remedies Private Limited

32. Global Cholestatic Pruritus Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cholestatic Pruritus Market

34. Recent Developments In The Cholestatic Pruritus Market

35. Cholestatic Pruritus Market High Potential Countries, Segments and Strategies

• 35.1 Cholestatic Pruritus Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Cholestatic Pruritus Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Cholestatic Pruritus Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer

관련자료